GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Other Income (Expense)

Chi Sheng Pharma & Biotech Co (ROCO:4111) Other Income (Expense) : NT$26 Mil (TTM As of Dec. 2024)


View and export this data going back to 1999. Start your Free Trial

What is Chi Sheng Pharma & Biotech Co Other Income (Expense)?

Chi Sheng Pharma & Biotech Co's other income expense for the Chi Sheng Pharma & Biotech Co's pretax income for the three months ended in Dec. 2024 was NT$11 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$26 Mil.

Chi Sheng Pharma & Biotech Co Other Income (Expense) Historical Data

The historical data trend for Chi Sheng Pharma & Biotech Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chi Sheng Pharma & Biotech Co Other Income (Expense) Chart

Chi Sheng Pharma & Biotech Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.29 13.39 8.62 13.13 25.95

Chi Sheng Pharma & Biotech Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.71 13.19 5.49 -3.54 10.82

Chi Sheng Pharma & Biotech Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chi Sheng Pharma & Biotech Co  (ROCO:4111) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Chi Sheng Pharma & Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Chi Sheng Pharma & Biotech Co Ltd (ROCO:4111) » Definitions » Other Income (Expense)
Comparable Companies
ROCO:4116 ROCO:6543 ROCO:6527 ROCO:6730 ROCO:4150 ROCO:7575 ROCO:6518 ROCO:4115 ROCO:6493 TPE:4737 ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN
Traded in Other Exchanges
N/A
Address
No. 3, Shijian Road, Hsin Chu Industrial Park, Hsinchu County, Hukou, TWN, 30316
Website
http://www.cscp.com.tw
Chi Sheng Pharma & Biotech Co Ltd manufactures and distributes medical medicines and equipment in Taiwan. It offers injections, including hemodialysis solutions, amino acid injections, vitamin injections, and externally applied medicines.

Chi Sheng Pharma & Biotech Co Headlines

No Headlines